411 REFERENCE · Wikipedia
1q21.1 deletion syndrome
Reference material by Wikipedia contributors. This retains its source identity and is not 411 news reporting.
1q21.1 deletion syndrome Chromosome 1q21.1 microdeletion syndrome, 1q21.1 microdeletion, Monosomy 1q21.1, Del(1)(q21), 1q21.1 contiguous gene deletion, 1q21.1 deletion, Chromosome 1q21.1 deletion syndrome, Chromosome 1q21.1 deletion syndrome, 1.35-Mb. Genetics. Delayed development, intellectual disability, physical abnormalities, neurological abnormalities and psychiatric problems. Infancy.2023-07-25 1q21.1 microdeletion syndrome — About the Disease — Genetic and Rare Diseases Information Center https://rarediseases.info.nih.gov/diseases/10813/1q211-microdeletion-syndrome https://web.archive.org/web/20170108170439/https://rarediseases.info.nih.gov/diseases/10813/1q211-microdeletion-syndrome dead January 8, 2017 rarediseases.info.nih.gov Deletion of genetic material on the long arm (or q arm) of chromosome 1 at position 21.1.Overview: 1q21.1 microdeletion syndrome http://rarediseases.info.nih.gov/gard/10813/1q211-microdeletion-syndrome/resources/1 Genetic and Rare Diseases Information Center (GARD) Office of Rare Diseases Research • U.S. National Institutes of Health 9 September 2013 8 August 2011 2 June 2013 https://web.archive.org/web/20130602152134/http://rarediseases.info.nih.gov/gard/10813/1q211-microdeletion-syndrome/resources/1 dead Chromosomal microarray analysis.Chad R. Haldeman-Englert Tamison Jewett 1q21.1 Recurrent Microdeletion 1q21.1 Recurrent Deletion https://www.ncbi.nlm.nih.gov/books/NBK52787/ University of Washington, Seattle 24 February 2011 Seattle (WA) 21348049 PubMed 22q11.2 microdeletion syndrome Coffin-Siris syndrome 0.015% of the population.M.A. Gillentine P.J. Lupo P. Stankiewicz C.P. Schaaf An estimation of the prevalence of genomic disorders using chromosomal microarray data Journal of Human Genetics July 2008 1434-5161 795–801 63 7 29691480 6019170 10.1038/s10038-018-0451-x
1q21.1 deletion syndrome is a rare aberration of chromosome 1. A human cell has one pair of identical chromosomes on chromosome 1. With the 1q21.1 deletion syndrome, one chromosome of the pair is not complete, because a part of the sequence of the chromosome is missing. One chromosome has the normal length and the other is too short.
In 1q21.1 the initial '1' stands for chromosome 1, the 'q' stands for the long arm of the chromosome and '21.1' stands for the part of the long arm in which the deletion is situated.
The syndrome is a form of the 1q21.1 copy number variations, and it is a deletion in the distal area of the 1q21.1 part. The CNV leads to a very variable phenotype, and the manifestations in individuals are quite variable. Some people who have the syndrome can function in a normal way, while others have symptoms of intellectual impairment and various physical anomalies.1q21.1 microdeletion: MedlinePlus Genetics https://medlineplus.gov/genetics/condition/1q211-microdeletion/ 2023-07-25 medlineplus.gov
1q21.1 microdeletion is a very rare chromosomal condition. As of 2024, only 102 people with 1q21.1 deletion syndrome have been identified in medical research.2023-11-17 Simons Searchlight 1q21.1 Deletion Syndrome https://www.simonssearchlight.org/gene-guide/1q21-1-deletion/ 2026-06-25 Simons Searchlight en-US
The recurrent 1q21.1 microdeletion was first identified in 2008 through a chromosomal microarray studies published in Nature Genetics and the New England Journal of Medicine.Brunetti-Pierri N. Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities Nature Genetics 2008 40 12 1466–1471 18784092 10.1038/ng.279 2680128 Mefford Heather C. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes New England Journal of Medicine 2008-10-16 359 16 1685–1699 18635433 2703742 10.1056/NEJMoa0805384
Signs and symptoms
Approximately 75% of all children with a 1q21.1 microdeletion exhibit delayed development, notably in motor skills such as sitting, standing, and walking. Individuals may have generalized mild learning difficulties; about 30% of those diagnosed with 1q21.1 deletion syndrome are affected.
Dysmorphic craniofacial traits are common, however, they are highly varied and thus difficult to identify. Microcephaly has been reported in 39% of those with the 1q21.1 deletion.
It is not clear whether the list of symptoms is complete. Very little information is known about the syndrome. The syndrome can have completely different effects on members of the same family.
Genitourinary abnormalities include vesicoureteral reflux, hydronephrosis, inguinal hernia, cryptorchidism, and genital malformations. There have been two reported cases of Mayer-Rokitansky-Kuster-Hauser syndrome alongside 1q21.1 deletion syndrome.Mei-Jou Chen Shin-Yi Wei Wei-Shiung Yang Tsai-Tzu Wu Concurrent exome-targeted next-generation sequencing and single nucleotide polymorphism array to identify the causative genetic aberrations of isolated Mayer-Rokitansky-Küster-Hauser syndrome Human Reproduction (Oxford, England) July 2015 1460-2350 1732–1742 30 7 25924657 10.1093/humrep/dev095 Huei-Ying Li Hong-Nerng Ho Yu-Shih Yang Pei-Lung Chen
The majority of affected people have normal neurologic physical examinations, however hypotonia and tremors are quite common. Seizures affect roughly 16% of children and typically begin during infancy.
Possible psychiatric and behavioral abnormalities include autism spectrum disorder, attention deficit hyperactivity disorder, and mood disorders. Furthermore, distal 1q21.1 microdeletions have been found in 0.2%-0.6% of those with schizophrenia.Hreinn Stefansson Dan Rujescu Sven Cichon Olli P. H. Pietiläinen Large recurrent microdeletions associated with schizophrenia Nature September 2008 1476-4687 232–236 455 7210 10.1038/nature07229 Andres Ingason Stacy Steinberg Ragnheidur Fossdal Engilbert Sigurdsson Thordur Sigmundsson Jacobine E. Buizer-Voskamp Thomas Hansen Klaus D. Jakobsen Pierandrea Muglia Clyde Francks Paul M. Matthews Arnaldur Gylfason Bjarni V. Halldorsson Daniel Gudbjartsson Thorgeir E. Thorgeirsson Asgeir Sigurdsson Adalbjorg Jonasdottir Aslaug Jonasdottir Asgeir Bjornsson Sigurborg Mattiasdottir Thorarinn Blondal Magnus Haraldsson Brynja B. Magnusdottir Ina Giegling Hans-Jürgen Möller Annette Hartmann Kevin V. Shianna Dongliang Ge Anna C. Need Caroline Crombie Gillian Fraser Nicholas Walker Jouko Lonnqvist Jaana Suvisaari Annamarie Tuulio-Henriksson Tiina Paunio Timi Toulopoulou Elvira Bramon Marta Di Forti Robin Murray Mirella Ruggeri Evangelos Vassos Sarah Tosato Muriel Walshe Tao Li Catalina Vasilescu Thomas W. Mühleisen August G. Wang Henrik Ullum Srdjan Djurovic Ingrid Melle Jes Olesen Lambertus A. Kiemeney Barbara Franke Chiara Sabatti Nelson B. Freimer Jeffrey R. Gulcher Unnur Thorsteinsdottir Augustine Kong Ole A. Andreassen Roel A. Ophoff Alexander Georgi Marcella Rietschel Thomas Werge Hannes Petursson David B. Goldstein Markus M. Nöthen Leena Peltonen David A. Collier David St Clair Kari Stefansson 18668039 2687075 2008Natur.455..232S 11858/00-001M-0000-0012-C93F-6
A common deletion is between 1.0-1.9Mb. Mefford states that the standard for a deletion is 1.35Mb.Mefford HC, Sharp AJ, Baker C Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes N. Engl. J. Med. 359 16 1685–99 October 2008 18784092 2703742 10.1056/NEJMoa0805384 etal https://archive-ouverte.unige.ch/unige:9219/ATTACHMENT01 2066/71235 2022-06-26 2018-11-04 https://web.archive.org/web/20220626001816/https://archive-ouverte.unige.ch/files/downloads/0/0/0/0/9/2/1/9/unige_9219_attachment01.pdf dead
Physical and clinical features reported in individuals with the distal 1q21.1 deletion are highly variable, ranging from no apparent findings to multiple congenital and developmental differences. Commonly affected systems include growth, neurological and motor function, heart development, vision, and behavior.
Growth and Development. Frequently described findings include failure to thrive, poor postnatal growth, short stature, microcephaly, and structural brain anomalies such as corpus callosum malformations. Eye findings may include strabismus, coloboma, and cataracts; opthalmologic involvement is reported in roughly one-third of individuals. Cardiac abnormalities such as septal defects, outflow-tract anomalies, and tetralogy of Fallot have been observed. Craniofacial findings such as high-arched palate have also been described.
Neurological and Behavioral. Neurological and motor features can include hypotonia (low muscle tone), motor delay, seizures and oral-motor dysfunction contributing to feeding or speech difficulties and excessive drooling (sialorrhea). Neurobehavioral traits described include attention deficit/hyperactivity disorder (ADHD), autistic characteristics, mood or anxiety disorders, sleep disturbance, self-injurious behavior, and, in some adults, psychotic disorders such as schizophrenia.
Families report mood swings, including intense temper outbursts such as screaming or aggression and oppositional behaviour. However, presentations vary, and individuals may also exhibit positive and engaging behaviour.1q21.1 microdeletions https://www.rarechromo.org/media/information/Chromosome%20%201/1q21.1%20microdeletions%20FTNW.pdf
Other findings. Musculoskeletal and genitourinary findings may include skeletal differences or urinary tract anomalies. Feeding and gastrointestinal issues such as dysphagia, gastroesophageal reflux, or gastroparesis may require individualized management, and G-tube feeding can be indicated when oral intake is insufficient. In one study of 68 subjects, dental deformities were reported in 10.3%.Upadhyai Priyanka Amiri Eram Fatima Guleria Vishal Singh Bielas Stephanie L. Girisha Katta Mohan Shukla Anju Recurrent 1q21.1 deletion syndrome: report on variable expression, nonpenetrance and review of literature https://pmc.ncbi.nlm.nih.gov/articles/PMC8555865/ Clinical Dysmorphology 29 3 127–131 10.1097/MCD.0000000000000327 1473-5717 8555865 32459673 Hearing loss has also been described.Guo Rose 1q21.1 Recurrent Deletion 2024-02-01 GeneReviews® [Internet] https://www.ncbi.nlm.nih.gov/books/NBK52787/ 2025-11-02 University of Washington, Seattle en 21348049 Haldeman-Englert Chad R.
Causes
1q21.1 deletion is autosomal dominant, with 18%-50% of deletions developing de novo and 50%-82% inherited from a parent.
The majority of affected individuals are missing a 1.35 million DNA base pair sequence, also written as 1.35 megabases (Mb), in the q21.1 region of chromosome 1, though the exact size of the deleted region differs. This deletion affects one of each cell's two copies of chromosome 1.
The symptoms caused by a 1q21.1 microdeletion are most likely due to the loss of many genes in this region. Researchers are attempting to determine which missing genes may contribute to 1q21.1 deletions' specific characteristics. Because some people with a 1q21.1 microdeletion have no clear associated traits, it is hypothesized that additional genetic and environmental factors influence the development of symptoms.
Diagnosis
The recurring distal 1.35-Mb heterozygous deletion within the position of 145–146.35 Mb in the reference genome confirms the diagnosis of 1q21.1 deletion. The copy number of sequences can be determined using chromosome microarrays or targeted deletion analysis by fluorescence in situ hybridization.
Differential diagnosis
22q11.2 microdeletion shares several characteristics with 1q21.1 microdeletion including developmental delays, learning disabilities, intellectual disability, and behavioral deviations. Those with recurrent 1q21.1 microdeletion, on the other hand, do not have the distinctive facial traits seen in the 22q11.2 microdeletion syndrome.
Management
Several examinations should be performed to determine the level of disability and the needs of a person with the 1q21.1 deletion. Because of the vast range of symptoms, ophthalmologic, cardiac, developmental, neurological, and psychiatric evaluations may be helpful in identifying the manifestations of 1q21.1 deletion. Different developmental abnormalities of the skull and genitourinary system can be identified with brain imaging and renal ultrasounds. Consultations with a medical geneticist or genetic counselor can aid in determining the cause of 1q21.1 deletion.
Because of the variability in 1q21.1 deletion, management is dependent on specific symptoms. Occupational and physical therapy, as well as special learning programs, may be used to manage symptoms. Feeding therapy may be used to address poor growth, with a low threshold for feeding evaluation and/or radiographic swallowing study when there are clinical signs or symptoms of dysphagia.
Epidemiology
Nonallelic homologous recombination (NAHR), mediated by low copy repeats (LCRs), is a well-known mechanism of copy number alterations in an array of genomic diseases. Individually, these conditions are uncommon, yet collectively, they impact a significant portion of the population. 1q21.1 deletions are estimated to occur in about 0.015% of the population. However, these CNVs are incompletely penetrant, therefore it is likely that the actual prevalence in the general population is greater than the current predictions.
Research
Statistical research showed that schizophrenia is more common in combination with 1q21.1 deletion syndrome. On the other side, autism is significantly more common with 1q21.1 duplication syndrome. Further research confirmed that the odds on a relation between schizophrenia and deletions at 1q21.1, 3q29, 15q13.3, 22q11.21 en Neurexin 1 (NRXN1) and duplications at 16p11.2 are at 7.5% or higher.Levinson DF, Duan J, Oh S Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications Am J Psychiatry 168 3 302–16 March 2011 21285140 4441324 10.1176/appi.ajp.2010.10060876 etalIkeda M, Aleksic B, Kirov G 26047827 Copy number variation in schizophrenia in the Japanese population Biol. Psychiatry 67 3 283–6 February 2010 19880096 10.1016/j.biopsych.2009.08.034 etal
thumb|right|500px|Observed relation within 1q21.1
Common variations in the BCL9 gene, which is in the distal area, confer risk of schizophrenia and may also be associated with bipolar disorder and major depressive disorder.Li J, Zhou G, Ji W Common variants in the BCL9 gene conferring risk of schizophrenia Arch. Gen. Psychiatry 68 3 232–40 March 2011 21383261 10.1001/archgenpsychiatry.2011.1 etal free
Research is done on 10–12 genes on 1q21.1 that produce DUF1220-locations. DUF1220 is an unknown protein, which is active in the neurons of the brain near the neocortex. Based on research on apes and other mammals, it is assumed that DUF1220 is related to cognitive development (man: 212 locations; chimpanzee: 37 locations; monkey: 30 locations; mouse: 1 location). It appears that the DUF1220-locations on 1q21.1 are in areas that are related to the size and the development of the brain. The aspect of the size and development of the brain is related to autism (macrocephaly) and schizophrenia (microcephaly). It has been proposed that a deletion or duplication of a gene that produces DUF1220-areas might cause growth and development disorders in the braine.g.: Dumas L, Sikela JM DUF1220 domains, cognitive disease, and human brain evolution Cold Spring Harb. Symp. Quant. Biol. 74 375–82 2009 19850849 2902282 10.1101/sqb.2009.74.025
Another relation between macrocephaly with duplications and microcephaly with deletions has been seen in research on the HYDIN Paralog or HYDIN2. This part of 1q21.1 is involved in the development of the brain. It is assumed to be a dosage-sensitive gene. When this gene is not available in the 1q21.1 area, it leads to microcephaly. HYDIN2 is a recent duplication (found only in humans) of the HYDIN gene found on 16q22.2.Doggett NA, Xie G, Meincke LJ A 360-kb interchromosomal duplication of the human HYDIN locus. Genomics 88 6 762–71 Dec 2006 16938426 10.1016/j.ygeno.2006.07.012 etal 1805/35618 free
Research on the genes CHD1L and PRKAB2 within lymphoblast cells 10.1186/1750-1172-6-54 6 Understanding the impact of 1q21.1 copy number variant 2011 Orphanet Journal of Rare Diseases 54 Harvard C 21824431 3180300 free lead to the conclusion that anomalies appear with the 1q21.1-deletion syndrome:
CHD1L is an enzyme which is involved in untangling the chromatids and the DNA repair system. With 1q21.1 deletion syndrome a disturbance occurs, which leads to increased DNA breaks. The role of CHD1L is similar to that of helicase with the Werner syndrome
PRKAB2 is involved in maintaining the energy level of cells. With 1q21.1-deletion syndrome this function was attenuated.
GJA5 has been identified as the gene that is responsible for the phenotypes observed with congenital heart diseases on the 1q21.1 location. In case of a duplication of GJA5 tetralogy of Fallot is more common. In case of a deletion other congenital heart diseases than tetralogy of Fallot are more common.Soemedi, R. DPhenotype-Specific Effect of Chromosome 1q21.1 Rearrangements and GJA5 Duplications in 2436 Congenital Heart Disease Patients and 6760 Controls Hum. Mol. Genet. 2011 10.1093/hmg/ddr589 21 7 1513–1520 etal 22199024 3298277
References
Further reading
Genetics of Mental Retardation, Karger. Knight S. (ed) Chapter One: 'A Parent's' Perspective' contains description and photos of female with 1q21.1 microdeletion
Brunet A, Armengol L, Heine D BAC array CGH in patients with Velocardiofacial syndrome-like features reveals genomic aberrations on chromosome region 1q21.1 BMC Med. Genet. 10 144 2009 20030804 2805625 10.1186/1471-2350-10-144 etal free
Brunetti-Pierri N, Berg JS, Scaglia F, Belmont J, Bacino CA, Sahoo T Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet 2008 40 12 1466–71 19029900 10.1038/ng.279 2680128 etal
Crespi B, Stead P, Elliot M Evolution in health and medicine Sackler colloquium: Comparative genomics of autism and schizophrenia Proc Natl Acad Sci U S A 2010 107 Suppl 1 1736–41 19955444 10.1073/pnas.0906080106 2868282 2010PNAS..107.1736C free
External links
62
1q21.1 deletion, GeneReviews NCBI Bookshelf
Orpha.net
LD44.10 Q93.5 612474 C567291 1q211-microdeletion 10813 250989
Category:Hematology
Category:Congenital disorders
Category:Syndromes affecting the nervous system
Category:Animal developmental biology
Category:Syndromes affecting the heart